Other

FDA approves Botox competitor that lasts longer

People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.

Neuroscience

Optimizing deep brain stimulation in patients with dystonia

Recent discoveries made by researchers from Charité – Universitätsmedizin Berlin may prove vital in improving the treatment of dystonia, a neurological movement disorder. Published in PNAS, their findings show that very ...

Medications

5 neurological conditions you can treat with Botox

You might know botulinum toxin as Botox: one of many brand names for the injectable drug that smooths wrinkles and facial creases. What you might not know is that botulinum toxin can also be used to treat migraines and ease ...

Medications

Patients may become immune to botulinum toxin treatments

(HealthDay)—About 15 percent of patients treated with botulinum toxin type A (BoNT/A) for dystonia or spasticity can develop an immune response to the treatment itself, according to a study published online Nov. 21 in Neurology.

Neuroscience

Redrawing the brain's motor map

Neuroscientists at Emory have refined a map showing which parts of the brain are activated during head rotation, resolving a decades-old puzzle. Their findings may help in the study of movement disorders affecting the head ...

page 1 from 2